期刊文献+

肝络通防治大鼠胆汁性肝纤维化门静脉高压症的初步研究 被引量:6

Preliminary study of Glytan on treating portal hypertension rats induced by biliary liver fibrosis
原文传递
导出
摘要 目的:探讨肝络通降低胆汁性肝纤维化引起的大鼠门静脉高压的作用机制。方法:取体质量240-260g左右的清洁级SD雄性大鼠156只,根据体质量随机分为假手术组、模型组、心得安组、肝络通高、中、低剂量组。采用胆总管结扎的方法造成大鼠胆汁性肝纤维化模型。术后2周和4周分别测定各组的门静脉压力,HE染色观察肝组织学的变化,检测血清肝功能,放免法定量体循环和肠系膜上动脉血浆内皮素-1的浓度。结果:术后2周和4周,模型组大鼠门静脉压力显著升高。心得安和肝络通在两个时间点有显著的降压作用。肝络通能显著抑制胶原生成,促进肝组织结构的恢复;肝功能显示肝络通在两个时间点均能显著降低血清丙氨酸氨基转移酶(AST)、门冬氨酸氨基转移酶的活性(ALT),血清总蛋白(TP)、白蛋白(ALB)、总胆红素(TBIL)的含量和Na+的浓度。门静脉高压症初期肝络通降低体循环内皮素-1的浓度,提高肠系膜循环的内皮素-1的浓度,抑制内脏血管的舒张。结论:肝络通通过改善肝功能,抑制胶原生成,调节肝内微循环,改善纤维化初期高动力循环,抑制水钠潴留,从而降低门静脉压力。 Objective: To investigate the mechanism of Glytan lowering portal pressure induced by biliary liver fibrosis. Methods: SD male rats, 240-260g weight around, were randomly divided into sham-operation group, model group, propranolol group, Glytan high-dose, middle-dose and low-dose group according to the weight. Portal hypertension was induced by common bile duct ligation in rats. After two and four weeks, measured the portal pressure(PP) of each group, observed the histological changes of liver by HE staining, tested liver function and the concentration of endothelin-1 in systemic circulation and mesenteric circulation radioimmnuoassay. Results: After two and four weeks, portal pressure of model group rats increased significantly. Both Glytan and propranolol can decrease PP after two and four weeks, and the pressure-relief effect was similar between the two drugs. HE staining showed that Glytan can significantly inhibit the formation of collagen, promote the recovery of liver tissue structure; liver function indicated a significant decrease in serum AST, ALT, TBIL and Na+ concentration. In addition, Glytan decreased the concentration of endothelin -1 in systemic circulation, increased it in mesenteric circulation after two weeks. Conclusion: Glytan decrease PP by improving liver function and microcirculation, inhibiting collagen formation and water-sodium retention after long-term therapy, ameliorating hyperdynamic circulation at the early stage.
出处 《中华中医药杂志》 CAS CSCD 北大核心 2009年第4期446-451,共6页 China Journal of Traditional Chinese Medicine and Pharmacy
基金 教育部长江学者和创新团队发展计划资助项目(No.IRT0413)
关键词 门静脉高压症 肝内微循环 高动力循环 肝络通 实验研究 Portal hypertension Liver microcirculation Hyperdynamic circulation Glytan Experimental study
  • 相关文献

参考文献10

  • 1Van de Casteele M, Hosli M, Sagesser H, Reichen J. Intraportal administration of glyceryl trinitrate or nitroprusside exerts more systemic than intrahepatic effects in anaesthetised cirrhotic rats. J Hepatol, 1999,31(2):300-305
  • 2刘平 沟口靖弘 森泽成司.镁—丹酚酸B抗大鼠实验性肝纤维化的作用[J].中国医药学报,1993,8:65-67.
  • 3胡义扬,刘平,刘成,顾宏图,徐列明,刘成海,季光.丹参提取物对CCl_4和DMN诱导的大鼠肝纤维化的影响[J].上海中医药杂志,1999,33(10):7-10. 被引量:156
  • 4Abraham Koshy, Andrea De Gottardi, Monika Ledermann, et al. Endothelial nitric oxide synthase is not essential for the development of fibrosis and portal hypertension in bile duct ligated mice. Liver International, 2005,25:1044-1052
  • 5Fernandez M, Mejias M, Angermayr B,et al.Inhibition of VEGF receptor-2 decreases the development of hyperdynamie splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rat.J Hepatol,2005 A3(1):98-103.
  • 6刘树锋,蔡大勇,李澎涛,相萍茹.优化甘参复方抗肝纤维化组分配伍的研究[J].中华中医药杂志,2005,20(6):373-375. 被引量:9
  • 7Garc i a-Pag 6 n J C, Navasa M, Rivera F,et al.Lymphocyte beta 2-adrenoceptors and plasma catecholamines in patients with cirrhosis. Gastroenterology, 1992,102:2015-2023
  • 8周扬,顾杰,徐列明.丹参酚酸B盐对肝硬化大鼠门静脉高压及肝组织中内皮素-1的影响[J].中国中西医结合消化杂志,2007,15(1):4-7. 被引量:15
  • 9Nagasue N, Dhar D K, Yamanoi A, et al. Production and Release of Endothelin-1 From the Gut and Spleen in Portal Hypertension Due to Cirrhosis. Hepatology,2000,31:1107-1114
  • 10Ikura Y, Ohsawa M, Naruko T, et al.Expression of the hepatic endothelin system in human cirrhotic livers. J Pathol, 2004,204:304-310

二级参考文献16

共引文献175

同被引文献58

引证文献6

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部